NO994613L - Anvendelse av en pulmonal alveolaer surfaktant for fremstilling av et medikament for behandling av sovnapne - Google Patents

Anvendelse av en pulmonal alveolaer surfaktant for fremstilling av et medikament for behandling av sovnapne

Info

Publication number
NO994613L
NO994613L NO19994613A NO994613A NO994613L NO 994613 L NO994613 L NO 994613L NO 19994613 A NO19994613 A NO 19994613A NO 994613 A NO994613 A NO 994613A NO 994613 L NO994613 L NO 994613L
Authority
NO
Norway
Prior art keywords
medication
preparation
treatment
sleep apnea
pulmonary alveolar
Prior art date
Application number
NO19994613A
Other languages
English (en)
Norwegian (no)
Other versions
NO994613D0 (no
Inventor
Keith Meyer
M Safwan Badr
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO994613D0 publication Critical patent/NO994613D0/no
Publication of NO994613L publication Critical patent/NO994613L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO19994613A 1997-04-16 1999-09-23 Anvendelse av en pulmonal alveolaer surfaktant for fremstilling av et medikament for behandling av sovnapne NO994613L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/834,369 US5958902A (en) 1997-04-16 1997-04-16 Method and composition for treating sleep apnea
PCT/US1998/007735 WO1998046245A1 (en) 1997-04-16 1998-04-16 Method and composition for treating sleep apnea

Publications (2)

Publication Number Publication Date
NO994613D0 NO994613D0 (no) 1999-09-23
NO994613L true NO994613L (no) 1999-10-28

Family

ID=25266775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994613A NO994613L (no) 1997-04-16 1999-09-23 Anvendelse av en pulmonal alveolaer surfaktant for fremstilling av et medikament for behandling av sovnapne

Country Status (24)

Country Link
US (3) US5958902A (ko)
EP (1) EP1009411B1 (ko)
JP (1) JP2001507364A (ko)
KR (1) KR100381643B1 (ko)
CN (1) CN1252727A (ko)
AR (1) AR012221A1 (ko)
AT (1) ATE298241T1 (ko)
AU (1) AU722866B2 (ko)
BG (1) BG103800A (ko)
BR (1) BR9809090A (ko)
CA (1) CA2285574C (ko)
CO (1) CO4940399A1 (ko)
DE (1) DE69830660T2 (ko)
HK (1) HK1026141A1 (ko)
HU (1) HUP0002645A3 (ko)
ID (1) ID29298A (ko)
IL (2) IL132133A0 (ko)
NO (1) NO994613L (ko)
NZ (1) NZ337969A (ko)
PL (1) PL336326A1 (ko)
SK (1) SK143199A3 (ko)
TR (1) TR199902577T2 (ko)
TW (1) TWI221771B (ko)
WO (1) WO1998046245A1 (ko)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6641542B2 (en) 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
CA2485530A1 (en) * 2002-02-15 2003-08-28 Cns, Inc. Throat spray
HUE031167T2 (hu) 2002-03-20 2017-07-28 Civitas Therapeutics Inc A levodopa pulmonális bejuttatása
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
JP2007190277A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器および呼吸訓練プログラム
JP2007190278A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190275A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
CA2641821C (en) * 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
US7748493B2 (en) * 2006-06-14 2010-07-06 Zmed Technologies, Inc. Respiration stimulation
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea
JP2011500143A (ja) 2007-10-09 2011-01-06 イムセラ・メディカル・インコーポレーテッド 選択的刺激のための装置、システム、及び方法
DK2230934T3 (da) 2007-12-14 2012-11-26 Aerodesigns Inc Afgivelse af aerosoliserbare næringsmiddelprodukter
EP2349139B1 (en) 2008-10-09 2017-05-31 Imthera Medical, Inc. Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue
EP2498868A4 (en) 2009-11-10 2013-05-08 Imthera Medical Inc SYSTEM FOR STIMULATING A HYPOGLOSSAL NERVO FOR CONTROLLING THE TONGUE POSITION IN A PATIENT
WO2012025892A2 (en) * 2010-08-26 2012-03-01 Ben Gurion University Of The Negev Research And Development Authority Apparatus and method for diagnosing obstructive sleep apnea
WO2012082791A2 (en) 2010-12-13 2012-06-21 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US10265013B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265014B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
CN105123927A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种芦荟健胃豆渣发酵乳及其制备方法
CN105010535A (zh) * 2015-07-30 2015-11-04 安徽人人福豆业有限公司 一种银耳豆渣发酵乳及其制备方法
CN105123928A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种润肠豆渣发酵乳及其制备方法
CN105123926A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种疏肝理气豆渣发酵乳及其制备方法
CN105053196A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种风味草莓豆渣发酵乳及其制备方法
CN105104535A (zh) * 2015-07-30 2015-12-02 安徽人人福豆业有限公司 一种养颜豆渣发酵乳及其制备方法
CN105053194A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种清热通络豆渣发酵乳及其制备方法
CN105053197A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种温中补血豆渣发酵乳及其制备方法
CN105053192A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种椰香补肾豆渣发酵乳及其制备方法
CN104996566A (zh) * 2015-07-30 2015-10-28 安徽人人福豆业有限公司 一种清肺酒香豆渣发酵乳及其制备方法
CN104982527A (zh) * 2015-07-30 2015-10-21 安徽人人福豆业有限公司 一种安神豆渣发酵乳及其制备方法
CN105053191A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种消食木瓜豆渣发酵乳及其制备方法
CN105053195A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种去火薄荷味豆渣发酵乳及其制备方法
US10786449B2 (en) 2017-07-17 2020-09-29 Northriver Pharm, LLC Nasal composition comprising a mucoadhesive polymer
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520234A1 (fr) * 1982-01-28 1983-07-29 Gros Pierre Composition destinee a la prevention du ronflement
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス　ノバ　インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量６，０００ダルトンのタンパク質及びその多量体
JPS63208524A (ja) * 1987-02-25 1988-08-30 Nippon Oil & Fats Co Ltd 睡眠リズム改善剤
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
WO1993021221A1 (en) * 1992-04-10 1993-10-28 Abbott Laboratories Pulmonary surfactant protein fragments
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance

Also Published As

Publication number Publication date
US20020099033A1 (en) 2002-07-25
AU722866B2 (en) 2000-08-10
HUP0002645A3 (en) 2002-12-28
CA2285574C (en) 2007-11-13
NZ337969A (en) 2001-12-21
KR20010006384A (ko) 2001-01-26
TR199902577T2 (xx) 2000-02-21
US6329352B1 (en) 2001-12-11
BR9809090A (pt) 2002-12-03
SK143199A3 (en) 2001-01-18
HUP0002645A2 (hu) 2001-06-28
IL132133A (en) 2008-12-29
DE69830660D1 (de) 2005-07-28
EP1009411A4 (en) 2002-10-09
DE69830660T2 (de) 2006-05-04
EP1009411B1 (en) 2005-06-22
CO4940399A1 (es) 2000-07-24
WO1998046245A1 (en) 1998-10-22
HK1026141A1 (en) 2000-12-08
US5958902A (en) 1999-09-28
KR100381643B1 (ko) 2003-04-26
IL132133A0 (en) 2001-03-19
CA2285574A1 (en) 1998-10-22
ATE298241T1 (de) 2005-07-15
JP2001507364A (ja) 2001-06-05
TWI221771B (en) 2004-10-11
CN1252727A (zh) 2000-05-10
BG103800A (en) 2000-03-31
ID29298A (id) 2001-08-16
PL336326A1 (en) 2000-06-19
AU6975598A (en) 1998-11-11
NO994613D0 (no) 1999-09-23
EP1009411A1 (en) 2000-06-21
AR012221A1 (es) 2000-09-27

Similar Documents

Publication Publication Date Title
NO994613L (no) Anvendelse av en pulmonal alveolaer surfaktant for fremstilling av et medikament for behandling av sovnapne
NO20035157D0 (no) Lungeadministrering av kjemisk modifisert insulin
AU8427891A (en) Obstructive sleep apnea collar
NO306850B1 (no) Anvendelse av 5-halo-2-pyrimidinon-deoksyribose eller 5-halo-2-pyrimidinon for fremstilling av et medikament for behandling av leversykdom
HUP0202755A3 (en) C-peptide for the improved production of insulin and insulin analogues
NO20002686D0 (no) Forbedring av Peyronies sykdom
PL356769A1 (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
PL351145A1 (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
NO20012831D0 (no) Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom
NO20023937D0 (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
FR2802852B3 (fr) Production d'elements figures
NO20014777D0 (no) Fremgangsmåte for behandling av flyveaske under anvendelse av saltsyre
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20003799L (no) Innkorporering av kolesterol senkende midler i konfekt- dosisformer
EE200100656A (et) Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud
HK1077216A1 (en) Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease
HUP0102929A3 (en) Use of levosimendan in the manufacture of a medicament for the treatment of pulmonary hypertension
NO981499D0 (no) Fremgangsmåte for fremstilling av titandioksyd
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
IL136663A0 (en) Use of substituted amino compounds in the treatment of chronic obstructive pulmonary disease
AU1271801A (en) Use of (r)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea
UA3446S (uk) Набір меблів до дитячої кімнати
NO20013453L (no) Fremgangsmate for fremstilling av salter av cyanobenzylaminer
HUP0000679A3 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application